メドビス

JP / EN

medbis
 

Breast Cancer Patient Support

Always Together with Breast Cancer Patients.

〜 We provide solutions for improved breast cancer treatment and care 〜

We offer custom genomics and molecular services for clinical diagnosis and develop products and devices for preventive and/or postoperative diagnosis and breast reconstruction comprehensively.

  1. Preventive Diagnosis : Genetic Screen for Risk AlleleCustom Services

    This service provides tests and analysis that find breast cancer risk alleles in a healthy person.

  2. Test for Postoperative Diagnosis : PAM50Custom Services

    PAM50 is a diagnostic assay that evaluates the risk of distant breast cancer recurrence by using profile data of the 50 genes related to the prognosis of invasive breast cancer. PAM50 test examines the activity of these 50 genes in breast cancer cells taken from resected patient tumors. Result in PAM50 provides the characteristic and the risk of recurrence in future in the patient’s breast cancer.

    more >

  3. Postoperative breast reconstruction with Endogenous Biological Microparticles(EBMs) (Under development) Medical Material

    • Feature 1 : New breast reconstruction technology with a less burden on the human body

      We develop new breast reconstruction technology using Endogenous Biological Microparticles(EBMs).Reconstructed breast with using our technology can keep shape of the breast long and less burdens for a human body.

    • Feature 2 : Establishment of novel breast reconstruction method in partnership with breast cancer specialists

      Breast reconstruction is currently performed by plastic surgery specialists or cosmetic surgeons. Therefore, breast cancer specialists are not involved in breast reconstruction surgery. Medbis proposes a new breast reconstruction technology that breast cancer specialists can offer in collaboration with plastic surgery specialists / cosmetic surgeons to improve patient quality of life(QOL).

  4. Research and Development in the latest screening methods and diagnostic assays by collaboration with KBCRN Development

    KBCRN (Kyoto Breast Cancer Research Network) is Japan’s largest and most prominent study group consisting of breast cancer experts and researchers. Medbis develops and evaluates diagnostic assays, devices, and screening methods discussed and shared with KBCRN. In addition, we contribute to breast cancer therapy as an incubator and accelerator of KBCRN.

Health Care

Bring innovative Health Science for all

〜 Challenge to “Aging” disease 〜

  1. Ainprose

    AinProse is a product researched and developed by General Incorporated Association Advalife Science. Our company distributes AinProse..

    more >

  2. “Re : A” : New-generation stem cell-based cosmetics using Japan’s domestic materials and Japan-made.Cosmetisc

    Stem cells secrete many physiologically active substances into the medium during cell culturing. Some reports show that more than 500 types of substances are secreted The functions of these active physiological substances can bring out the skin potential, which is expected to realise the future type of anti-ageing care. Re:A contains a high-concentrated Endogenous Biological Microparticles(EBMs). The theory is that Re:A promotes the regeneration of skin tissue by taking active physiological substances secreted by stem cells into the skin and body.

    • Feature 1 : Formulation for Japanese

    • Feature 2 : Uses only Japan’s domestic materials and made in Japan

    • Feature 3 : Successful mixture/formulation of high-concentrated Endogenous Biological Microparticles(EBMs) from years of research.

    more >

ラボ

Assessment Institution : Connects patients, medical institutions and academic institutions.

～ Roles as Reference Laboratory : Information dissemination from Kyoto Research Park at Kyoto University. 〜

Medbis is a research institution having the role of Reference Laboratory and do scientific and technical survey and assessment in diagnostic agents & devices and inspection methods depending on requests from researchers while collaborating with academic and medical institutions. ＊Inspection/Work in progress

  1. PAM50

    PAM50 is a diagnostic assay that evaluates the risk of distant breast cancer recurrence by using profile data of the 50 genes related to the prognosis of invasive breast cancer. PAM50 test examines the activity of these 50 genes in breast cancer cells taken from resected patient tumors. Result in PAM50 provides the characteristic and the risk of recurrence in future in the patient’s breast cancer.

    more >

  2. Gene Expression Analysis by using nCounter Analysis System

    <nCounter Analysis System> The nCounter Analysis System is a gene analysis system developed by NanoString Technologies, USA, based on an innovative concept. By utilizing sequence-specific probes with unique fluorescent molecular barcodes, it allows for the digital counting of up to 800 target sequences, ensuring accuracy and high reproducibility. Since it does not require enzymatic reactions such as reverse transcription or PCR amplification, it is particularly powerful for analyzing samples where nucleic acids are expected to be fragmented, such as those derived from FFPE (Formalin-fixed paraffin-embedded)tissues.

  3. Gene Expression Analysis

    The pre-designed gene expression panels of nCounter® offer a variety of panels mainly focused on cancer and immunology, enabling gene expression analysis tailored to research purposes. All panels are created based on the opinions of experts in each field and are regularly updated. With NanoString’s Panel Pro selection tool, you can easily search for panels that include the genes you want to analyze. For example, the Pan Cancer Panels, ideal for cancer research, each feature 770 key cancer-related genes. These include the Pan Cancer Pathway Panel, which covers 124 driver genes and 606 pathway-related genes; the Pan Cancer Immune Panel, which allows simultaneous analysis of cancer-related and immune-related genes; and the Pan Cancer Progression Panel, designed to deepen the understanding of genes involved in cancer progression. These panels provide multiplex gene expression analysis that enables pathway deregulation, immunoprofiling, and foundational and translational research on cancer progression. In addition to these, there are many other panels for immunology and cancer research, and customization is also available.

臨床研究支援

Clinical Research Support for connecting Researchers and Patients

〜We support you with the best skill in every step of clinical research and development, from planning to launching into the market, including pharmaceutical and regenerative products, and medical devices.〜

Medbis strongly supports you with the best skills and various end-to-end services from planning to launching into the market. Our support helps researchers create favourable conditions to make a social contribution freely.

Our services include:

人

「Kizuna -meaning bond-」 〜bond People-to-People, People with innovation

～Medbis is a group of passionate intellectuals and professionals Experts making best efforts with passion to explore encounters and opportunities with people.〜

Medbis continuously strives to provide an exciting, friendly and sustainable working environment for our employees to maximise and realise our potential. Excellence and compassion are our team’s core strengths. Our strengths help bridge the distances while building a trusted relationship between our customers and us to provide solutions and improve quality of life.
 

TOP